azathioprine has been researched along with Pulmonary Alveolar Proteinosis in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Pulmonary Alveolar Proteinosis: A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griese, M | 1 |
| Ripper, J | 1 |
| Sibbersen, A | 1 |
| Lohse, P | 2 |
| Brasch, F | 1 |
| Schams, A | 1 |
| Pamir, A | 1 |
| Schaub, B | 1 |
| Muensterer, OJ | 1 |
| Schön, C | 1 |
| Glöckner-Pagel, J | 1 |
| Nicolai, T | 1 |
| Reiter, K | 1 |
| Hector, A | 1 |
1 other study available for azathioprine and Pulmonary Alveolar Proteinosis
| Article | Year |
|---|---|
Long-term follow-up and treatment of congenital alveolar proteinosis.
Topics: Adrenal Cortex Hormones; Azathioprine; Bronchoalveolar Lavage; Child; Female; Granulocyte-Macrophage | 2011 |